Table 2.
Results of the regression analysis assessing the influence of leg position as well as probe localization on microcirculation under compression therapy
| sO2 | Flow | |||
| CCLI | CCLII | CCLI | CCLII | |
| Diabetes mellitus | ||||
| Baseline | 0.497*** (0.383, 0.611) |
0.295*** (0.189, 0.400) |
0.583*** (0.435, 0.731) |
0.778*** (0.572, 0.984) |
| Elevation | −17.546*** (−23.119, −11.973) |
−13.961*** (−19.053, −8.870) |
−41.754*** (−57.781, −25.728) |
−22.119* (−45.058, 0.821) |
| Standing | −10.434*** (−16.115, −4.752) |
−6.493*** (−11.692, −1.295) |
−31.253*** (−46.931, −15.575) |
1.102 (−21.400, 23.603) |
| Toe | 0.819 (−4.207, 5.845) |
9.164*** (4.561, 13.767) |
9.683 (−4.081, 23.447) |
21.367** (1.794, 40.940) |
| Intercept | 26.859*** (20.705, 33.013) |
33.064*** (27.312, 38.816) |
44.410*** (29.794, 59.026) |
19.232* (−1.436, 39.899) |
| Observations | 255 | 257 | 263 | 263 |
| Peripheral arterial disease | ||||
| Baseline | 0.346*** (0.229, 0.463) |
0.461*** (0.349, 0.573) |
0.481*** (0.375, 0.587) |
0.511*** (0.410, 0.611) |
| Elevation | −26.205*** (−32.217, −20.193) |
−21.155*** (−27.033, −15.277) |
−50.650*** (−64.974, −36.325) |
−43.930*** (−57.465, −30.395) |
| Standing | −12.359*** (18.408, −6.310) |
−9.494*** (−15.412, −3.576) |
−25.690*** (−39.646, −11.734) |
−17.737*** (−30.928, −4.546) |
| Toe | 3.963 (−1.280, 9.206) |
4.266 (−0.850, 9.383) |
9.483 (−2.720, 21.686) |
7.353 (−4.188, 18.893) |
| Intercept | 34.792*** (28.165, 41.419) |
27.765*** (21.421, 34.110) |
50.806*** (37.726, 63.885) |
45.853*** (33.494, 58.211) |
| Observations | 257 | 257 | 262 | 263 |
All results were correlated to the reference position Sit/M2.
*P<0.1, **P<0.05, ***P<0.01.
CCLI, compression class I; CCLII, compression class II; sO2, oxygen saturation of hemoglobin.